Skip to content

Drug interactions

Osilodrostat + Pimavanserin

Severity: Moderate

Osilodrostat and Pimavanserin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can prolong the QT interval. Together they may increase the risk of torsades de pointes, particularly if the patient has hypokalemia, bradycardia or cardiac disease.

What this interaction means in plain words

Osilodrostat and Pimavanserin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Osilodrostat belongs to Endocrine; Pimavanserin belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Additive QT prolongation.

What to do

Obtain a baseline ECG and monitor it during treatment; correct potassium and magnesium abnormalities. Avoid the combination in patients with a prolonged QTc or other QT-prolonging drugs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Osilodrostat and Pimavanserin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Osilodrostat with Pimavanserin?

MediHelp rates the interaction as moderate. Osilodrostat and Pimavanserin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can prolong the QT interval. Together they may increase the risk of torsades de pointes, particularly if the patient has hypokalemia, bradycardia or cardiac disease.

How serious is the interaction between Osilodrostat and Pimavanserin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor it during treatment; correct potassium and magnesium abnormalities. Avoid the combination in patients with a prolonged QTc or other QT-prolonging drugs.

What other medicines interact with Pimavanserin?

MediHelp also lists interactions of Pimavanserin with, for example, Lefamulin, Pimozide, Vandetanib. The full list is on the Pimavanserin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in